Eisai
4523.T
#2257
Rank
โ‚น724.68 B
Marketcap
โ‚น2,569
Share price
-1.64%
Change (1 day)
8.46%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): โ‚น73.02

According to Eisai's latest financial reports the company's current EPS (TTM) is โ‚น77.63. an increase over its 2024 EPS that were of โ‚น87.52.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2025โ‚น97.8911.85%
2024โ‚น87.52-32.63%
2023โ‚น129.915.52%
2022โ‚น123.12-74.01%
2021โ‚น473.66-66.58%
2020โ‚น1,41798.24%
2019โ‚น714.8317.01%
2018โ‚น610.9037.78%
2017โ‚น443.40-27.62%
2016โ‚น612.6235.33%
2015โ‚น452.69-2.82%
2014โ‚น465.84-27.66%
2013โ‚น643.99-27.49%
2012โ‚น888.18-12.67%
2011โ‚น1,01788.08%
2010โ‚น540.77-11.06%
2009โ‚น608.04-390.15%
2008-โ‚น209.56-127.78%
2007โ‚น754.4611.78%
2006โ‚น674.974.38%
2005โ‚น646.677.4%
2004โ‚น602.1443.03%
2003โ‚น421.0025.09%
2002โ‚น336.5552.67%
2001โ‚น220.4469.76%
2000โ‚น129.86